<DOC>
	<DOCNO>NCT00117780</DOCNO>
	<brief_summary>This trial conduct Europe . The aim research study compare efficacy ( reduction HbA1c blood glucose level ) insulin detemir daily injection compare insulin detemir twice daily injection administer basal insulin treatment type 1 diabetes verify safety use ( number severity episodes hypoglycemia , body weight side effect ) .</brief_summary>
	<brief_title>Comparison Insulin Detemir Given Once Twice Daily Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Type 1 diabetes 1 year Subject treat kind insulin regimen whatever number injection HbA1c = 7.5 % = 10 % Type 2 diabetes Treatment oral antidiabetic drug Severe medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>